ArticleFrontiers in microbiology2022
Detection of
Xiaoling Zheng, Yinhuan Wang, WanZi Gong, Qianru Cai, Jue Li, Jiequn Wu
Abstract read
In one paragraphArticle in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Xiaoling ZhengNational Medical Products Administration (NMPA) Key Laboratory for Testing and Risk Warning of Pharmaceutical Microbiology, Key Laboratory of Drug Contacting Materials Quality Control of Zhejiang Provincial, Zhejiang Institute for Food and Drug Control, Hangzhou, China.
Yinhuan WangNational Medical Products Administration (NMPA) Key Laboratory for Testing and Risk Warning of Pharmaceutical Microbiology, Key Laboratory of Drug Contacting Materials Quality Control of Zhejiang Provincial, Zhejiang Institute for Food and Drug Control, Hangzhou, China.
WanZi GongNational Medical Products Administration (NMPA) Key Laboratory for Testing and Risk Warning of Pharmaceutical Microbiology, Key Laboratory of Drug Contacting Materials Quality Control of Zhejiang Provincial, Zhejiang Institute for Food and Drug Control, Hangzhou, China.
Qianru CaiCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceutical, Zhejiang University of Technology, Hangzhou, China.
Jue LiNational Medical Products Administration (NMPA) Key Laboratory for Testing and Risk Warning of Pharmaceutical Microbiology, Key Laboratory of Drug Contacting Materials Quality Control of Zhejiang Provincial, Zhejiang Institute for Food and Drug Control, Hangzhou, China.
Jiequn WuCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceutical, Zhejiang University of Technology, Hangzhou, China.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
To eliminate the influences of excipients and interference of dead bacterial DNA on the detection of
Indexed as
Bacillus licheniformis live capsuleEscherichia coliprobioticspropidium monoazidePseudomonas aeruginosaqPCRSalmonella paratyphoid BShigella dysentery
Identifiers
PMID36160211
PMCPMC9493680
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390